Samrat Pharmachem Ltd
Samrat Pharmachem Ltd Live Price Chart
Performance
| Previous Close | ₹ |
| High | ₹ |
| Volume | 411 |
| 52W Range | ₹ - ₹ |
| Open | ₹ |
| Low | ₹ |
| Market Cap | ₹ 78 Cr |
Samrat Pharmachem Ltd Technicals
| 20 Day | ₹ 214.571 |
| 50 Day | ₹ 214.879 |
| 100 Day | ₹ 222.195 |
| 200 Day | ₹ 249.338 |
| 20 Day | ₹ 215.993 |
| 50 Day | ₹ 213.166 |
| 100 Day | ₹ 213.119 |
| 200 Day | ₹ 248.317 |
Samrat Pharmachem Ltd Fundamentals
| ROCE | -2.568 |
| P/E Ratio | -19.480 |
| P/B Ratio | 0.950 |
| Industry P/E | 0.950 |
| Debt to Equity | 44.960 |
| ROE | -4.858 |
| EPS | -10.720 |
| Dividend Yield | 0.000 |
| Book Value | 220.668 |
| Face Value | 10.000 |
Samrat Pharmachem Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 286.8339 | 282.9658 | 311.1236 | 222.3846 | 179.4806 |
| Total Expenses | 276.9478 | 280.4456 | 288.5932 | 198.7837 | 172.1191 |
| Profit After Tax | 7.1122 | 2.1626 | 16.6305 | 17.1848 | 5.3332 |
Samrat Pharmachem Ltd Shareholding Pattern
| Promoter Holdings | 49.091 % |
| FIIs | 3.237 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 41.746 % |
| Others - | 5.926 % |
About Samrat Pharmachem Ltd
Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta. Since then, it envisioned to focus on lodine Derivatives as their core products. The Company's principal activities are manufacturing and selling chemicals. Company is a producer of pharmaceutical chemicals. The intermediates produced are used in pharmaceutical and chemical industries. Your Company is amongst the manufacturers who produce for local and international needs of the pharmaceuticals and chemicals industry. The company has two plants producing varied items. The basic purpose of producing in two different plants is to improve efficiency and manageability. SPL started commercial production of Iodine Derivatives in April, 1993. In October 1996, SPL acquired adjoining land for increasing its production capacity to cater to larger markets. The Company floated a new 100% subsidiary company during the year 2003-04 under the name of 'Samrat Remedies Limited' to carry on activities of Manufacturing of Pharmaceutical Bulk Drugs & Chemicals. SPL constructed new factory building in July, 2006. In August 2015, SPL received GMP Compliance Certificate and was awarded with Export House Certificate by Government of India in October 2015. SPL installed machinery for enhancing its production capacity in April 2019. ...
